Medicine & Health News

TAU research finds clues to the mystery of consciousness in new brain study

Tel Aviv University (TAU) researchers have found that the brain’s response to sound remains powerful during sleep in all parameters but one: the level of alpha-beta waves associated with attention to the auditory input and related expectations. This means that during sleep, the brain analyzes the auditory input but is unable to focus on the… Read More

Fourth dose of COVID-19 vaccine reduces risk of death in the elderly by 72%

A new study by Tel Aviv University (TAU) and Ben Gurion University of the Negev, in collaboration with the Israeli Ministry of Health, has found that a fourth dose of the existing COVID-19 vaccine is effective in protecting the elderly population in long-term care facilities from the Omicron variant. The research was based on a… Read More

TAU experiment uses CRISPR-Cas to successfully diagnose diseases in space

Tel Aviv University (TAU) researchers recently conducted a unique experiment in the International Space Station to test genetic diagnosis under microgravity conditions using the CRISPR system, a sort of molecular “search engine.” They proved that CRISPR-Cas  can be used to precisely and reliably identify viruses and bacteria infecting crew members during space missions. The study… Read More

Professor Karen Avraham elected Dean of Tel Aviv University’s medical faculty

Professor Karen Avraham was selected last week as the next Dean of the Faculty of Medicine at Tel Aviv University (TAU). She is the first woman appointed to the position. Professor Avraham’s tenure begins on September 1, 2022. She previously served as Vice Dean for Pre-Clinical Affairs at the Faculty of Medicine. “Medicine is undergoing… Read More

COVID-19 variants originate in immunocompromised patients, TAU researchers say

A new Tel Aviv University (TAU) study reveals that many SARS-CoV-2 variants are likely formed in chronic COVID-19 patients who suffer from immunosuppression. The researchers suggest that a weakened antibody response, particular in the lower airways of these chronic patients, may prevent full recovery from the virus and drive the virus to mutate many times… Read More

TAU technology offers single-injection treatment for HIV infection

A new study from Tel Aviv University (TAU) offers a new and unique treatment for AIDS which may be developed into a vaccine or a one-time treatment for patients with HIV. The study examined the engineering of type B white blood cells in the patient’s body to secrete anti-HIV antibodies in response to the virus…. Read More